Reference centres for adults with rare and complex cancers - Policy recommendations to improve the organisation of care in Belgium
- PMID: 26745998
- DOI: 10.1016/j.respe.2015.11.006
Reference centres for adults with rare and complex cancers - Policy recommendations to improve the organisation of care in Belgium
Abstract
Background: Rare and/or complex cancers call for a very specific expertise and adequate infrastructure. In Belgium, every hospital with a programme in oncology can deliver care for adults with rare and/or complex cancer types, without having demonstrated a specific know-how to adequately manage these patients. Therefore, the Minister of Health ordered a scenario for the organisation of care for adults with rare and/or complex cancers, taking into account the current Belgian situation and relevant foreign experience.
Methods: Combined methods were used in this study: a literature review, the consultation of stakeholders, in depth discussions in 14 multidisciplinary groups leading to concrete proposals for several rare/complex cancers and the consultation of a panel of expert pathologists.
Results: The core recommendation is the set-up of shared care networks around reference centres, with multidisciplinary teams of recognised expertise in specific rare/complex cancers. The definition of minimum caseloads for hospitals and medical specialists, the evaluation of the quality of care, a model of diagnostic confirmation and the set-up of a national portal website which provides information on rare and/or complex cancers and reference centres are highly recommended.
Conclusion: It is no longer practicable, efficient or ethical that every hospital or every practitioner continues to offer care for every rare/complex cancer. Improving the quality of rare/complex cancer care requires to concentrate expertise and sophisticated infrastructure in reference centres. Furthermore, the formation of networks between reference centres and peripheral centres will allow a delivery of care combining expertise and proximity. The next step is the translation of the recommendations into policy decisions. It is very well realised that this will take some courage and that a certain degree of resistance will have to be surmounted, but eventually, the best interest of the patient should prevail.
Keywords: Cancer care facilities; Centralized hospital services; Hospital; Hôpital; Maladies rares; Oncology service; Rare diseases; Referral and consultation; Référencement et consultation; Services d’oncologie; Services hospitaliers centralisés.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.
Similar articles
-
[Care networks in oncology, an evidence for all?].Bull Cancer. 2013 Jul-Aug;100(7-8):650-4. Bull Cancer. 2013. PMID: 24063023 French. No abstract available.
-
Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.Nefrologia. 2011;31(6):664-9. doi: 10.3265/Nefrologia.pre2011.Oct.11001. Nefrologia. 2011. PMID: 22130281 English, Spanish.
-
Policy statement on multidisciplinary cancer care.Eur J Cancer. 2014 Feb;50(3):475-80. doi: 10.1016/j.ejca.2013.11.012. Epub 2013 Dec 6. Eur J Cancer. 2014. PMID: 24321260
-
[Rare disease: centre of expertise or care guideline?].Ned Tijdschr Geneeskd. 2014;158:A8062. Ned Tijdschr Geneeskd. 2014. PMID: 25336315 Dutch.
-
Improving treatment results with reference centres for rare cancers: where do we stand?Eur J Cancer. 2017 May;77:90-98. doi: 10.1016/j.ejca.2017.02.006. Epub 2017 Apr 3. Eur J Cancer. 2017. PMID: 28384534 Review.
Cited by
-
Holistic view of patients with melanoma of the skin: how can health systems create value and achieve better clinical outcomes?Ecancermedicalscience. 2019 Aug 27;13:959. doi: 10.3332/ecancer.2019.959. eCollection 2019. Ecancermedicalscience. 2019. PMID: 31645887 Free PMC article. Review.
-
Rare disease care pathways in the EU: from odysseys and labyrinths towards highways.J Community Genet. 2021 Apr;12(2):231-239. doi: 10.1007/s12687-021-00520-9. Epub 2021 Mar 18. J Community Genet. 2021. PMID: 33738760 Free PMC article.
-
An Evaluation of Rare Cancer Policies in Europe: A Survey Among Healthcare Providers.Cancers (Basel). 2025 Jan 7;17(2):164. doi: 10.3390/cancers17020164. Cancers (Basel). 2025. PMID: 39857946 Free PMC article.
-
Varying viewpoints of Belgian stakeholders on models of interhospital collaboration.BMC Health Serv Res. 2018 Dec 4;18(1):942. doi: 10.1186/s12913-018-3763-9. BMC Health Serv Res. 2018. PMID: 30514304 Free PMC article.
-
Rare diseases: still on the fringes of universal health coverage in Europe.Lancet Reg Health Eur. 2023 Dec 11;37:100783. doi: 10.1016/j.lanepe.2023.100783. eCollection 2024 Feb. Lancet Reg Health Eur. 2023. PMID: 38169941 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous